Elderly Japanese patients with a high geriatric nutritional risk index (GNRI) were associated with significantly better Clostridioides difficile infection (CDI) relapse-free survival compared with those with low GNRI.
The nutritional status of elderly patients may determine their risk of recurrent Clostridioides difficile infection (CDI), according to study findings published in Journal of Rural Medicine.
CDI recurrence is a significant health care burden contributing to high risk of morbidity, mortality, and cost. Older age (> 65 years) is known to be an important risk factor for recurrent CDI, and as the world’s aging population increases, researchers note that identifying risk for CDI in these elderly patients has become an urgent matter.
“Many recent studies have reported an association between nutritional status and various diseases. The geriatric nutritional risk index (GNRI) is a simple and objective tool that uses serum albumin levels and body mass index (BMI) to assess the nutritional status of older patients. A low GNRI has been reported to be an adverse prognostic factor in patients with various diseases,” explained the study authors.
They conducted a retrospective observational study to investigate the relationship between CDI relapse and nutritional status using the GNRI. Patients hospitalized between January 2016 and December 2021 at the Iwate Prefectural Senmaya Hospital, located in a rural area of Japan, were examined for the analysis.
Total hospitalization, mean patient age, and length of hospital stay (LOS) among the cohort of pateints were 219,022; 79.4 years; and 21.0 days, respectively. A total of 108 patients with fever and diarrhea received a CDI diagnosis during hospitalization, of which 19 were excluded because of younger age (< 65 years), early death within 14 days of the initial CDI diagnosis, and insufficient data.
The study cohort (N = 89) were divided into low- (< 75) and high-GNRI groups (≥ 75) based on the receiver operating characteristic curve analysis. Variables associated with CDI relapse were also analyzed, and they were age, sex, BMI, duration of hospitalization prior to the initial diagnosis of CDI, medical condition (chronic kidney disease [CKD]), antibiotics administered prior to the initial diagnosis of CDI, laboratory findings at initial diagnosis of CDI, severity of CDI, treatment for CDI, relapse of CDI, and LOS.
Overall, the median GNRI scores in all patients and in the low- and high-GNRI groups were 74.9, 68.9, and 83.9, respectively. Age was significantly higher in the low-GNRI group (P = .009), who also reported longer LOS (P = .003), vs the high-GNRI group. BMI and serum albumin levels, which are components of the GNRI, were significantly lower in the low-GNRI group than in the high-GNRI group.
Of the 89 patients, 28 (31.8%) experienced a CDI relapse. Findings of the log-rank test showed a significantly better relapse-free survival (RFS) in the high-GNRI group (P = .002).
Univariate analysis revealed that low GNRI (P = .004), CKD (P = .004) and beta-lactamase inhibitor administration before the initial diagnosis of CDI (P = .025) were significantly correlated with RFS. Multivariate analysis further revealed that low GNRI (P = .008) and CKD (P = .010) were independent prognostic factors for RFS.
“The GNRI is a simple and strong tool to assess the nutritional status of elderly patients; administration of vancomycin or fidaxomicin, which has a lower risk of treatment failure or relapse of CDI than metronidazole, should be considered for patients with CDI with low GNRI,” concluded the study authors.
Reference
Kumagai H, Shioi Y, Tamura D, Shitomi T, Tono C. Geriatric nutritional risk index as a risk-factor for Clostridioides difficile infection relapse in elderly Japanese patients. J Rural Med. 2022;17(4):248-254. doi:10.2185/jrm.2022-027
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More